Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Medipost, Inc.

Clinical trials sponsored by Medipost, Inc., explained in plain language.

Medipost, Inc. 078160 KOSDAQ

A Korean biotech specializing in stem cell therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

Stem cells from umbilical cord blood tested to repair knee cartilage

Disease control Completed

This early-phase trial tested a stem cell product called CARTISTEM in 12 adults with knee cartilage defects. The stem cells, derived from human umbilical cord blood, were implanted into the knee to see if they could safely help repair damaged cartilage. The study measured knee fu…

Phase: PHASE1, PHASE2 • Sponsor: Medipost, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:00 UTC